Verona Pharma Plc Insider Trades

VRNA

Track insider trading activity from Verona Pharma Plc executives and directors. See which insiders are buying and selling VRNA stock.

Trades Last 12 Months

VRNA Price

All Insider Trades for Verona Pharma Plc

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $0 0 shares
Last Trade
Oct 07, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.7M 72,000 shares
$106.91
$106.91
Austwick Michael Director
Holding Value $7.7M 72,000 shares
Last Trade
Oct 07, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.7M 72,000 shares
$106.91
$106.91
Rickard Kathleen A. Chief Medical Officer
Holding Value $121M 1,131,984 shares
Last Trade
Oct 07, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$121M 1,131,984 shares
$106.91
$106.91
Shah Mahendra Director
Holding Value $7.7M 72,000 shares
Last Trade
Oct 07, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.7M 72,000 shares
$106.91
$106.91
Sinha Vikas Director
Holding Value $0 0 shares
Last Trade
Oct 07, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$52.9M 494,496 shares
$106.91
$106.91
Ullman Anders Director
Holding Value $0 0 shares
Last Trade
Oct 07, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$103M 958,856 shares
$106.91
$106.91
Zaccardelli David President And CEO
Holding Value $0 0 shares
Last Trade
Oct 07, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.3B 12,176,144 shares
$106.91
$106.91
Holding Value $0 0 shares
Last Trade
Oct 07, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$69.2M 647,176 shares
$106.91
$106.91
Holding Value $0 0 shares
Last Trade
Oct 07, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.7M 72,000 shares
$106.91
$106.91
Deschamps Lisa Director
Holding Value $0 0 shares
Last Trade
Oct 07, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.7M 72,000 shares
$106.91
$106.91
Ebsworth David R Director
Holding Value $0 0 shares
Last Trade
Oct 07, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.7M 72,000 shares
$106.91
$106.91
Edwards Martin Director
Holding Value $0 0 shares
Last Trade
Oct 07, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.7M 72,000 shares
$106.91
$106.91
Fisher Andrew General Counsel
Holding Value $0 0 shares
Last Trade
Oct 07, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$66.2M 618,760 shares
$106.91
$106.91
Hahn Mark W Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Oct 07, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.2B 11,264,968 shares
$106.91
$106.91
Poll Claire General Counsel
Holding Value $126M 1,176,920 shares
Last Trade
Feb 01, 2024 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$2.16M 116,592 shares
$18.52
$106.91
Holding Value $441M 4,123,091 shares
Last Trade
May 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.22M 359,713 shares
$20.08
$106.91
Gupta Rishi Director
Holding Value $441M 4,123,091 shares
Last Trade
May 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.22M 359,713 shares
$20.08
$106.91
Blavatnik Len Director
Holding Value $5.98B 55,911,648 shares
Last Trade
Aug 15, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$59.9M 4,800,000 shares
$12.48
$106.91
Sinclair Andrew Director
Holding Value $6.84M 64,000 shares
Last Trade
Aug 09, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$391k 64,000 shares
$6.11
$106.91

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up